ArticleAlpha psychiatry2024

The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project-Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol.

Francesco Bartoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.